A detailed history of Bank Pictet & Cie (Asia) LTD transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Bank Pictet & Cie (Asia) LTD holds 46,020 shares of SOPH stock, worth $152,326. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,020
Previous 46,020 -0.0%
Holding current value
$152,326
Previous $227 Million 7.1%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$4.21 - $5.62 $96,830 - $129,260
-23,000 Reduced 33.32%
46,020 $227 Million
Q4 2022

Feb 17, 2023

BUY
$1.71 - $2.98 $7,866 - $13,708
4,600 Added 7.14%
69,020 $142 Million
Q1 2022

May 04, 2022

BUY
$7.31 - $15.6 $470,910 - $1 Million
64,420 New
64,420 $498,000

Others Institutions Holding SOPH

About SOPHiA GENETICS SA


  • Ticker SOPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 64,153,700
  • Market Cap $212M
  • Description
  • SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...
More about SOPH
Track This Portfolio

Track Bank Pictet & Cie (Asia) LTD Portfolio

Follow Bank Pictet & Cie (Asia) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Pictet & Cie (Asia) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bank Pictet & Cie (Asia) LTD with notifications on news.